Speaker 09.16.26
09.16
Breakthrough Trends & Digital Health Investment
11:40AM - 12:10PM EDT
Quorum by Convene
1221 Avenue of the Americas
New York, NY 10020
Ron Fleming Jr. represents entrepreneurs and financiers of leading startups in a diverse group of industries including software, ecommerce, cloud computing, video games, cleantech and sports.
Ron, the leader of Pillsbury’s Emerging Companies team in New York, maintains a broad-based corporate practice that encompasses securities offerings and compliance, venture capital, mergers and acquisitions, and general corporate law. He also focuses on emerging private and public companies and the technology, biotechnology and telecommunications industries.
Representative Experience
- Represented a clinical stage biotechnology company in its sale to a privately held pharmaceutical manufacturer.
- Represented a leading defense and space manufacturing company in its venture financings.
- Has represented Business Insider Inc. since formation, including incorporation, seven rounds of venture capital and its sale to Axel Springer SE.
View More
- Represented a Fortune 500 NYSE technology company in over a dozen acquisitions in the sensor and connector segments.
- Represented the first “unicorn” in New York in its organization and six rounds of venture capital financing with proceeds of over $300 million.
- Representing an internet messaging company/ASP in its IPO and follow-on convertible debt offering, over a dozen acquisitions (including two other Nasdaq-traded companies) and strategic venture investments and general securities compliance work.
- Representing the leading Latin American portal in its IPO.
- Representing a European ASP in its proposed IPO.
- Representing an international wireless telecommunications company in its IPO, two Rule 144A high-yield debt offerings, a convertible debt placement, a debt exchange/consent solicitation and general securities compliance work.
- Representing a privately held pharmaceutical company in its sale to a publicly traded Israeli pharmaceutical company.
- Representing the equity-trading division of a major bank in structuring “equity line” facilities for several publicly traded biotechnology companies.
- Representing a French fiber-optics equipment provider in its first and second round venture financings, a proposed acquisition of a specialty glass company and various commercial arrangements with leading telecom equipment manufacturers.
- Representing a public electronic connector company in its proposed acquisition of a Nasdaq-traded company, a public offering and general securities compliance work.
- Representing a Nasdaq-traded network appliance manufacturer in connection with its merger with a publicly traded Canadian IT services firm and general securities compliance work.
- Representing a broadcast software company in acquisition of a division of a public company, its first-round venture financing and various commercial and joint venture arrangements with leading media concerns.
- Representing an Asian application service provider in its first-round venture financing; representing the investors in a third-round venture financing by an email security company.
- Representing a drug discovery company in connection with its organization and angel funding.
- Representing the investors in second-round venture financing by a telecom networking company.
- Representing the placement agent in third-round venture financing by a leading online jewelry purveyor.
- Representing the placement agent in third-round venture financing by a customer management software company.
- Representing an ISP in its sale to a CLEC.
- Representing a German internet appliance software provider in multiple strategic venture investments and in its proposed IPO.
- Representing the placement agent in second-round venture financing for a provider of 3D visualization web-enabling software.
- Representing a commercial high-resolution satellite imaging company in its first-round venture financing.
- Representing a direct broadcast satellite provider in its offering of $2 billion of high-yield debt securities and in its strategic venture investment in an Israeli-based satellite broadband company.
- Representing a European-specialized mobile radio service provider in its $210 million first-round venture financing.
- Representing a commodities exchange in the financing of its new trading facilities in the first U.S. capital markets offering by a stock or commodities exchange.
- Representing a software provider in negotiating the terms of equity securities to be received in settlement of a technology ownership dispute with a major auction site.
Professional Highlights
- Recognized by Chambers USA, Startups & Emerging Companies (2024–2026)
- Recognized by The Legal 500 U.S.in Venture Capital and Emerging Companies (2025–2026)
- Recognized by Best Lawyers (published by BL Rankings LLC), Corporate Law (2005–2023)
Education
-
J.D., Columbia Law School, 1991
Harlan Fiske Stone Scholar, Advanced Interdisciplinary Legal Education ProgramB.A., Columbia University, 1991
summa cum laude, Phi Beta Kappa
Admissions
-
New York